Round voting button logo

SR732

A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Introduced·5/14/26

Senate resolution affirming mifepristone's safety and effectiveness, advocating for equitable and evidence-based abortion care policies.

This resolution expresses the Senate's belief that mifepristone, a medication used for abortion, is safe and effective based on over 25 years of evidence and numerous peer-reviewed studies. It calls for policies governing access to medication abortion to be equitable, transparent, and grounded in the best available scientific evidence. The resolution highlights the importance of maintaining access to mifepristone, especially for marginalized communities, and emphasizes the need for FDA policies to be based on scientific review and to consider potential burdens on patient access.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health, Education, Labor, And Pensions Committee
Next
Committee decision

Sponsors

DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDII
47
0
Democratic CaucusRepublican Caucus

History

May 14

Senate

Submitted in Senate

May 14

Senate

Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310)